Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details)

v3.21.1
Summary of Significant Accounting Policies (Details) - USD ($)
 1 Months Ended 12 Months Ended
Feb. 28, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net loss   $ (7,793,897) $ (3,927,662)  
Working Capital   2,800,000    
Cash and cash equivalents   3,157,256 3,057,682 $ 3,258,077
Grant revenue   428,129 0  
Cost of product revenue   428,129 0  
Impairment in the value of long-lived assets   20,660 $ 14,707  
Cash, FDIC Insured Amount   $ 250,000    
Finite-Lived Intangible Asset, Useful Life   20 years    
Potentially dilutive shares outstanding (in shares)   1,541,518 2,633,043  
Pre Funded Warrants        
Exercise price (in dollars per share)   $ 0.001    
Subsequent event | February 2021 Public Offering        
Net proceeds from offering $ 21,200,000      
B TRAN Devices | Diversified Technologies Inc | Recognized from 2020-2022        
Grant revenue   $ 1,200,000    
Supplier contract term   2 years